Antimicrobial Agents and Chemotherapy 2010-05-01

3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.

Lin Li, Lili He, Suiyi Tan, Xinhua Guo, Hong Lu, Zhi Qi, Chungen Pan, Xiuli An, Shibo Jiang, Shuwen Liu

Index: Antimicrob. Agents Chemother. 54(5) , 1700-11, (2010)

Full Text: HTML

Abstract

Heterosexual transmission is the primary route by which women acquire human immunodeficiency virus (HIV)/AIDS. Thus, development of woman-controlled topical microbicides for prevention of sexual transmission of HIV is urgently needed. Here we report that 3-hydroxyphthalic anhydride-modified chicken ovalbumin (HP-OVA) exhibits potent antiviral activity against a broad spectrum of human immunodeficiency virus type 1 (HIV-1) isolates with different genotypes and biotypes. Its antiviral activity is correlated with the percentages of the chemically modified and unmodified lysines and arginines in OVA. HP-OVA inhibits HIV-1 fusion and entry through multiple mechanisms of action, including (i) blocking gp120 binding to CD4 and (ii) interfering with gp41 six-helix bundle formation. Because of the widespread availability and established safety profile of OVA, HP-OVA has good potential to be developed as an effective, safe, and affordable microbicide for prevention of HIV sexual transmission.


Related Compounds

Related Articles:

The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification.

2003-06-01

[Antiviral Res. 59(1) , 23-33, (2003)]

[Antiviral activity of 3-hydroxyphthalic anhydride-modified ovalbumin against herpes simplex virus 2 in vitro].

2011-06-01

[Nan Fang Yi Ke Da Xue Xue Bao 31(7) , 1175-8, (2011)]

3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.

2013-03-01

[J. Antimicrob. Chemother. 68(3) , 573-6, (2013)]

Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.

2011-04-15

[J. Acquir. Immune Defic. Syndr. 56(5) , 384-92, (2011)]

More Articles...